Since formation in 1994, Proteome Sciences has been a global pioneer and leader in proteomics addressing differential protein expression in disease. Following the expansion of its activities after publication of the preliminary sequence of the human genome in 2001, the management team, Board of Directors and Scientific Advisory Board has been expanded to enhance commercial, scientific, technical and financial management.